Laterodorsal tegmental stimulation elicits dopamine efflux in the rat nucleus accumbens by activation of acetylcholine and glutamate receptors in the ventral tegmental area-Reference-Cited by-同舟云学术

Laterodorsal tegmental stimulation elicits dopamine efflux in the rat nucleus accumbens by activation of acetylcholine and glutamate receptors in the ventral tegmental area

Published:2000-10 Issue:10 Volume:12 Page:3596-3604
ISSN:0953-816X
Container-title:European Journal of Neuroscience
language:en
Short-container-title:European Journal of Neuroscience

Author:

Forster Gina L.,Blaha Charles D.

Publisher

Wiley

Subject

General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1460-9568.2000.00250.x/fullpdf

Reference82 articles.

1. Ultrastructural localization of the alpha4-subunit of the neuronal acetylcholine nicotinic receptor in the rat substantia nigra;Arroyo-Jiménez;J. Neurosci.,1999

2. M2 muscarinic autoreceptors modulate acetylcholine release in the medial pontine reticular formation;Baghdoyan;J. Pharmacol. Exp. Ther.,1998

3. Neuropharmacological mechanisms of drug reward: beyond the nucleus accumbens;Bardo;Crit. Rev. Neurobiol.,1998

4. Lesions of the tegmental pedunculopontine nucleus: effects on the locomotor activity induced by morphine and amphetamine;Bechara;Pharmacol. Biochem. Behav.,1992

5. The cholinergic innervation of the rat substantia nigra: a light and electron microscope immunohistochemical study;Beninato;Exp. Brain Res.,1988

Cited by 211 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct cholinergic circuits underlie discrete effects of reward on attention;Frontiers in Molecular Neuroscience;2024-08-29

2. Muscarinic receptors mediate motivation via preparatory neural activity in humans;2024-08-13

3. Muscarinic receptors mediate motivation via preparatory neural activity in humans;2024-08-13

4. The mesopontine tegmentum in reward and aversion: From cellular heterogeneity to behaviour;Neuroscience & Biobehavioral Reviews;2024-07

5. Muscarinic Receptor Activators as Novel Treatments for Schizophrenia;Biological Psychiatry;2024-03